Added to YB: 2023-08-28
Pitch date: 2023-08-28
CRNX:US [bullish]
Crinetics Pharmaceuticals, Inc.
+118.18%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Market Cap
$4.0B
Pitch Price
$17.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.08
P/E
-7.31
EV/Sales
149.89
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Crinetics Pharmaceuticals Inc CRNX:US
A summary for this pitch has not been created yet.
Read full article (0 min)